Ticker Details
Glaukos Corporation Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.
IPO Date:	June 25, 2015
Sector:	Healthcare
Industry:	Medical Instruments and Equipment
Market Cap:	$7.06B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.77 | 2.02%
Avg Daily Range (30 D):	$2.52 | 1.88%
Avg Daily Range (90 D):	$2.61 | 2.23%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.67M
Avg Daily Volume (90 D):	.67M

Trade Size
Avg Trade Size (Sh.):	66
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	6,255
Avg Institutional Trade:	$3.2M
Avg Institutional Trade (30 D):	$7.26M
Avg Institutional Trade (90 D):	$6.69M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.73M
Avg Closing Trade (30 D):	$13.88M
Avg Closing Trade (90 D):	$13.19M
Avg Closing Volume:	62.83K

News

May 11, 2026 @ 5:00 PM Presbyopia Market to Witness Accelerated Growth at... Source: Delveinsight

Sep 4, 2025 @ 5:30 AM Nicox prévoit de rembourser intégralement se... Source: Nicox Sa

Sep 4, 2025 @ 5:30 AM Nicox Expects to Fully Repay Financial Debts with ... Source: Gavin Spencer

Sep 11, 2024 @ 6:20 PM Glaukos Stocks Rides on Strong Product Demand Amid... Source: Zacks

Jul 16, 2024 @ 2:30 PM Will WATCHMAN Sales Aid Boston Scientific's (BSX) ... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.28	$-2.33	$-3.28
Diluted EPS	$-3.28	$-2.33	$-3.28
Revenue	$507.44M	$143.12M	$507.44M
Gross Profit	$282.76M	$-1.52M	$282.76M
Net Income / Loss	$-187.69M	$-133.66M	$-187.69M
Operating Income / Loss	$-199.6M	$-139.87M	$-199.6M
Cost of Revenue	$111.81M	$31.77M	$111.81M
Net Cash Flow	$-80.52M	$-6.62M	$-80.52M
PE Ratio